Is it necessary to measure plasma levels of anticancer drugs?
Variability in plasma drug levels in patients given the same doses of anticancer agents suggests that the efficacy of the drugs may also differ. Stress is laid on the need in clinical trials to make concomitant measurements of the plasma levels of drugs used.